EMA
approval
· 2019-03-29
New gene therapy to treat rare inherited blood condition
Summary
The EMA announces a new gene therapy intended to treat a rare inherited blood condition, signaling a novel treatment option for affected patients.
Upgrade for the full analysis, importance score, and drug timeline.